Evidence map›Paper›PMID 35066057›Full record

ArticleDiabetes research and clinical practice2022

Glycated albumin and HbA1c as markers of lower extremity disease inUS adults with and without diabetes.

Caitlin W Hicks, Dan Wang, Kunihiro Matsushita, John W McEvoy, Robert Christenson, Elizabeth Selvin

Open access · greenAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Risk of imbalanced glycemic pattern: diagnostic content validity.Revista da Escola de Enfermagem da U S P · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Elevated HbA1c level associated with disease severity and surgical extension in diabetic foot patients.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Caitlin W HicksDivision of Vascular Surgery and Endovascular Therapy, Johns Hopkins University School of Medicine, Baltimore MD, United States.
Dan WangDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, United States.
Kunihiro MatsushitaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, United States.
John W McEvoyNational Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland.
Robert ChristensonDepartment of Pathology, University of Maryland School of Medicine, Baltimore MD, United States.
Elizabeth SelvinDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD, United States. Electronic address: eselvin@jhu.edu.
Johns Hopkins University · USJohns Hopkins Medicine · USOllscoil na Gaillimhe – University of Galway · IEUniversity of Maryland, Baltimore · US

Funding

Risk Factors and Outcomes Associated with Late-Life Diabetic Peripheral NeuropathyK23DK124515 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HICKS, CAITLIN WHITNEY · 2020 to 2024
$898k
Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 DiabetesK24HL152440 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SELVIN, ELIZABETH · 2020 to 2024
$612k
National Trend and Predictors of Critical Limb Ischemia HospitalizationsR21HL133694 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MATSUSHITA, KUNIHIRO · 2016 to 2017
$245k
NHLBI NIH HHS K24 HL152440NHLBI NIH HHS R21 HL133694NIDDK NIH HHS K23 DK124515
6 · The paper itself

Abstract

aimWe evaluated the associations of two biomarkers of hyperglycemia-hemoglobin A1c(HbA1c) and glycated albumin-with lower extremity disease in US adultsoverall and by diabetes status.

methodsWe conducted a cross-sectional study of adult participants aged ≥ 40 years who attended the National Health and Nutrition Examination Survey (NHANES) 1999-2004 (unweighted N = 5,785). We used logistic regression to evaluate the associations of HbA1c and glycated albumin with lower extremity disease: peripheral neuropathy (assessed by monofilament test), peripheral artery disease (assessed by ankle-brachial index), history of foot ulcer, or amputation. All analyses were weighted and accounted for the complex NHANES sample survey design.

resultsThe prevalence of lower extremity disease was 17.4% (15.9% in adults without diabetes and 33.2% in adults with diabetes). HbA1c and glycated albumin were not significantly associated with lower extremity disease in adults without diabetes. However, we observed significant associations of both HbA1c (OR 1.19 per 1-% point increase, 95 %CI 1.06-1.34) and glycated albumin (OR 1.06 per 1-% point increase, 95 %CI 1.02-1.10) with lower extremity disease in adults with diabetes after adjustment. The patterns of association were similar for HbA1c and glycated albumin (P-for-seemingly-unrelated-regression = 0.60), with strong linear associations observed at high (diabetic) levels of both biomarkers.

conclusionsOur study suggests the importance of diabetes prevention and glycemic control in adults with diabetes to reduce the burden of lower extremity disease.

Indexed as

Diabetes MellitusGlycation End Products, AdvancedAdultBiomarkersBlood GlucoseCross-Sectional StudiesGlycated HemoglobinGlycated Serum AlbuminHumansLower ExtremityNutrition SurveysRisk FactorsSerum AlbuminBiomarkersBlood GlucoseGlycated HemoglobinGlycated Serum AlbuminGlycation End Products, AdvancedSerum AlbuminAmputationGlycated albuminhemoglobin A1cLower extremity diseasePeripheral artery diseasePeripheral neuropathy

Identifiers

PMID35066057
PMCPMC8917067
OpenAlexW4206494057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.